Yermus R, Bottos J, Bryson N, De Leo J, Earleywine M, Hackenburg E
Psychedelic Med (New Rochelle). 2025; 2(2):87-95.
PMID: 40051583
PMC: 11613527.
DOI: 10.1089/psymed.2023.0021.
Efthimiou A, Cardinale A, Kepa A
Psychedelic Med (New Rochelle). 2025; 2(4):221-233.
PMID: 40051482
PMC: 11658384.
DOI: 10.1089/psymed.2023.0058.
Gold N, Podrebarac S, White L, Marini C, Simon N, Mittelman M
Psychedelic Med (New Rochelle). 2025; 1(2):87-97.
PMID: 40046728
PMC: 11658675.
DOI: 10.1089/psymed.2022.0011.
Valdez T, Patel V, Senesombath N, Hatahet-Donovan Z, Hornick M
Pharmaceuticals (Basel). 2024; 17(11).
PMID: 39598395
PMC: 11597566.
DOI: 10.3390/ph17111484.
Kishon R, Modlin N, Cycowicz Y, Mourtada H, Wilson T, Williamson V
Npj Ment Health Res. 2024; 3(1):33.
PMID: 38956330
PMC: 11220096.
DOI: 10.1038/s44184-024-00068-9.
Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis.
Basedow L, Majic T, Hafiz N, Algharably E, Kreutz R, Riemer T
Sci Rep. 2024; 14(1):14782.
PMID: 38926480
PMC: 11208433.
DOI: 10.1038/s41598-024-65391-9.
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.
Zaretsky T, Jagodnik K, Barsic R, Antonio J, Bonanno P, MacLeod C
Curr Neuropharmacol. 2024; 22(4):636-735.
PMID: 38284341
PMC: 10845102.
DOI: 10.2174/1570159X22666231027111147.
Looking for Ted: black trips, "psychedelic" humanism, and silence.
Cordova M
Front Psychol. 2023; 14:1198371.
PMID: 37941757
PMC: 10629115.
DOI: 10.3389/fpsyg.2023.1198371.
Can research on entactogens contribute to a deeper understanding of human sexuality?.
Holka-Pokorska J
Pharmacol Rep. 2023; 75(6):1381-1397.
PMID: 37935915
PMC: 10661745.
DOI: 10.1007/s43440-023-00552-7.
The possible place for psychedelics in pharmacotherapy of mental disorders.
Wojtas A
Pharmacol Rep. 2023; 75(6):1313-1325.
PMID: 37934320
PMC: 10661751.
DOI: 10.1007/s43440-023-00550-9.
Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.
Nayak S, Jackson H, Sepeda N, Mathai D, So S, Yaffe A
Front Psychiatry. 2023; 14:1199642.
PMID: 37795509
PMC: 10545967.
DOI: 10.3389/fpsyt.2023.1199642.
Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence.
Inserra A, Piot A, De Gregorio D, Gobbi G
CNS Drugs. 2023; 37(9):733-754.
PMID: 37603260
DOI: 10.1007/s40263-023-01008-5.
Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings.
Garel N, Thibault Levesque J, Sandra D, Lessard-Wajcer J, Solomonova E, Lifshitz M
Front Hum Neurosci. 2023; 17:1200393.
PMID: 37533588
PMC: 10390742.
DOI: 10.3389/fnhum.2023.1200393.
The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics.
Evens R, Schmidt M, Majic T, Schmidt T
Ther Adv Psychopharmacol. 2023; 13:20451253231172254.
PMID: 37284524
PMC: 10240558.
DOI: 10.1177/20451253231172254.
The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.
Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L
Psychopharmacology (Berl). 2022; 239(11):3461-3483.
PMID: 35939083
PMC: 9358368.
DOI: 10.1007/s00213-022-06187-5.
Psychedelic-Assisted Psychotherapy-A Systematic Review of Associated Psychological Interventions.
Cavarra M, Falzone A, Ramaekers J, Kuypers K, Mento C
Front Psychol. 2022; 13:887255.
PMID: 35756295
PMC: 9226617.
DOI: 10.3389/fpsyg.2022.887255.
Restorative Retelling for Processing Psychedelic Experiences: Rationale and Case Study of Complicated Grief.
Gonzalez D, Aixala M, Neimeyer R, Cantillo J, Nicolson D, Farre M
Front Psychol. 2022; 13:832879.
PMID: 35592178
PMC: 9111738.
DOI: 10.3389/fpsyg.2022.832879.
Differential contributions of serotonergic and dopaminergic functional connectivity to the phenomenology of LSD.
Lawn T, Dipasquale O, Vamvakas A, Tsougos I, Mehta M, Howard M
Psychopharmacology (Berl). 2022; 239(6):1797-1808.
PMID: 35322297
PMC: 9166846.
DOI: 10.1007/s00213-022-06117-5.
The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility.
Wolff M, Mertens L, Walter M, Enge S, Evens R
J Psychopharmacol. 2022; 36(3):387-408.
PMID: 35253518
PMC: 8902683.
DOI: 10.1177/02698811211073758.
The Potential of Psychedelics for End of Life and Palliative Care.
Yaden D, Nayak S, Gukasyan N, Anderson B, Griffiths R
Curr Top Behav Neurosci. 2021; 56:169-184.
PMID: 34958455
DOI: 10.1007/7854_2021_278.
